84 related articles for article (PubMed ID: 8540348)
1. Mutants of HIV-1 protease with enhanced stability to autodegradation.
Tomasselli AG; Mildner AM; Rothrock DJ; Sarcich JL; Lull J; Leone J; Heinrikson RL
Adv Exp Med Biol; 1995; 362():387-98. PubMed ID: 8540348
[No Abstract] [Full Text] [Related]
2. Site-directed mutagenesis of HIV-1 protease: generation of mutant proteases with increased stability to autodigestion.
Tomasselli AG; Mildner AM; Rothrock DJ; Sarcich JL; Lull J; Leone J; Heinrikson R
Adv Exp Med Biol; 1995; 362():473-7. PubMed ID: 8540360
[No Abstract] [Full Text] [Related]
3. Identification of amino acid residues of the retroviral aspartic proteinases important for substrate specificity and catalytic efficiency.
Cameron CE; Burstein H; Bizub-Bender D; Ridky T; Weber IT; Wlodawer A; Skalka AM; Leis J
Adv Exp Med Biol; 1995; 362():399-406. PubMed ID: 8540349
[No Abstract] [Full Text] [Related]
4. Mechanism of autoprocessing of a mini-precursor of the aspartic protease of human immunodeficiency virus type 1.
Co E; Koelsch G; Hartsuck JA; Tang J
Adv Exp Med Biol; 1995; 362():379-86. PubMed ID: 8540347
[No Abstract] [Full Text] [Related]
5. Cloning, isolation, expression and mutagenesis studies on the human immuno-deficiency virus type 1 (HIV-1) protease.
Garner JC; Shoolingin-Jordan PM
Biochem Soc Trans; 1998 Aug; 26(3):S287. PubMed ID: 9766006
[No Abstract] [Full Text] [Related]
6. Conformational stability and catalytic activity of HIV-1 protease are both enhanced at high salt concentration.
Szeltner Z; Polgár L
J Biol Chem; 1996 Mar; 271(10):5458-63. PubMed ID: 8621402
[TBL] [Abstract][Full Text] [Related]
7. Activities of precursor and tethered dimer forms of HIV proteinase.
Phylip LH; Griffiths JT; Mills JS; Graves MC; Dunn BM; Kay J
Adv Exp Med Biol; 1995; 362():467-72. PubMed ID: 8540359
[No Abstract] [Full Text] [Related]
8. The HIV-1 protease as enzyme and substrate: mutagenesis of autolysis sites and generation of a stable mutant with retained kinetic properties.
Mildner AM; Rothrock DJ; Leone JW; Bannow CA; Lull JM; Reardon IM; Sarcich JL; Howe WJ; Tomich CS; Smith CW
Biochemistry; 1994 Aug; 33(32):9405-13. PubMed ID: 8068616
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the substrate envelope hypothesis for inhibitors of HIV-1 protease.
Chellappan S; Kairys V; Fernandes MX; Schiffer C; Gilson MK
Proteins; 2007 Aug; 68(2):561-7. PubMed ID: 17474129
[TBL] [Abstract][Full Text] [Related]
10. Solvation effects are responsible for the reduced inhibitor affinity of some HIV-1 PR mutants.
Sussman F; Villaverde MC; Davis A
Protein Sci; 1997 May; 6(5):1024-30. PubMed ID: 9144773
[TBL] [Abstract][Full Text] [Related]
11. Proteolysis of an active site peptide of lactate dehydrogenase by human immunodeficiency virus type 1 protease.
Tomaszek TA; Moore ML; Strickler JE; Sanchez RL; Dixon JS; Metcalf BW; Hassell A; Dreyer GB; Brooks I; Debouck C
Biochemistry; 1992 Oct; 31(42):10153-68. PubMed ID: 1420138
[TBL] [Abstract][Full Text] [Related]
12. Solution NMR evidence that the HIV-1 protease catalytic aspartyl groups have different ionization states in the complex formed with the asymmetric drug KNI-272.
Wang YX; Freedberg DI; Yamazaki T; Wingfield PT; Stahl SJ; Kaufman JD; Kiso Y; Torchia DA
Biochemistry; 1996 Aug; 35(31):9945-50. PubMed ID: 8756455
[TBL] [Abstract][Full Text] [Related]
13. A folding inhibitor of the HIV-1 protease.
Broglia RA; Provasi D; Vasile F; Ottolina G; Longhi R; Tiana G
Proteins; 2006 Mar; 62(4):928-33. PubMed ID: 16385559
[TBL] [Abstract][Full Text] [Related]
14. Secondary structure and signal assignments of human-immunodeficiency-virus-1 protease complexed to a novel, structure-based inhibitor.
Yamazaki T; Nicholson LK; Torchia DA; Stahl SJ; Kaufman JD; Wingfield PT; Domaille PJ; Campbell-Burk S
Eur J Biochem; 1994 Jan; 219(1-2):707-12. PubMed ID: 8307036
[TBL] [Abstract][Full Text] [Related]
15. Molecular dynamics studies on HIV-1 protease: a comparison of the flap motions between wild type protease and the M46I/G51D double mutant.
Lauria A; Ippolito M; Almerico AM
J Mol Model; 2007 Nov; 13(11):1151-6. PubMed ID: 17786489
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of the dimerization of retroviral proteases: the "fireman's grip" and dimerization.
Ingr M; Uhlíková T; Strísovský K; Majerová E; Konvalinka J
Protein Sci; 2003 Oct; 12(10):2173-82. PubMed ID: 14500875
[TBL] [Abstract][Full Text] [Related]
17. Revisiting monomeric HIV-1 protease. Characterization and redesign for improved properties.
Louis JM; Ishima R; Nesheiwat I; Pannell LK; Lynch SM; Torchia DA; Gronenborn AM
J Biol Chem; 2003 Feb; 278(8):6085-92. PubMed ID: 12468541
[TBL] [Abstract][Full Text] [Related]
18. Combining mutations in HIV-1 protease to understand mechanisms of resistance.
Mahalingam B; Boross P; Wang YF; Louis JM; Fischer CC; Tozser J; Harrison RW; Weber IT
Proteins; 2002 Jul; 48(1):107-16. PubMed ID: 12012342
[TBL] [Abstract][Full Text] [Related]
19. Total chemical synthesis of a D-enzyme: the enantiomers of HIV-1 protease show reciprocal chiral substrate specificity [corrected].
Milton RC; Milton SC; Kent SB
Science; 1992 Jun; 256(5062):1445-8. PubMed ID: 1604320
[TBL] [Abstract][Full Text] [Related]
20. Crystallographic analysis of human immunodeficiency virus 1 protease with an analog of the conserved CA-p2 substrate -- interactions with frequently occurring glutamic acid residue at P2' position of substrates.
Weber IT; Wu J; Adomat J; Harrison RW; Kimmel AR; Wondrak EM; Louis JM
Eur J Biochem; 1997 Oct; 249(2):523-30. PubMed ID: 9370363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
